SCRI - Florida Cancer Specialists - Panhandle Research Office — Tallahassee, Florida

SCRI - Florida Cancer Specialists - Panhandle Research Office is a clinical research site located in Tallahassee, Florida, United States 32308.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

SCRI - Florida Cancer Specialists - Panhandle Research Office has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non-Squamous Non-Small Cell Lung Cancer.

Sponsors: Mirati Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tallahassee

Browse all research sites in Florida · View every site in Tallahassee

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Florida Cancer Specialists - Panhandle Research Office?

SCRI - Florida Cancer Specialists - Panhandle Research Office has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Florida Cancer Specialists - Panhandle Research Office conducted?

SCRI - Florida Cancer Specialists - Panhandle Research Office has 1 clinical trials on record. Their work covers Metastatic Non-Squamous Non-Small Cell Lung Cancer.

Is SCRI - Florida Cancer Specialists - Panhandle Research Office accredited by Crixeo Clinical Trials?

SCRI - Florida Cancer Specialists - Panhandle Research Office has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Florida Cancer Specialists - Panhandle Research Office?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.